We studied the effect of treatment with diethylcarbamazine (DEC) on immune responses to parasite antigens in humans infected with Brugia malayi. In vitro lymphocyte proliferative responses to microfilarial antigens increased in patients who became amicrofilaremic after treatment with DEC. No changes in reactivity were observed in amicrofilaremic individuals who were given DEC or in a small number of patients who remained microfilaremic after treatment. Reactions to other antigens (PPD and SKSD) were not affected by drug treatment. Serum titers of antibodies to the sheath of B. malayi microfilariae did not significantly change during the period of observation. These findings indicate that DEC partially reverses the state of cellular unresponsiveness to parasite antigens associated with patient filarial infections.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Implementation of Mass Drug Administration for Lymphatic Filariasis in Madagascar: The Progress, Effectiveness and Financial Savings of Integrating into an Existing Polio Campaign.
Res Rep Trop Med
December 2024
Madagascar Country Office, World Health Organization, Antananarivo, Madagascar.
Introduction: This paper presents (a) the progress made towards achieving the 2023 Lymphatic Filariasis (LF) Mass Drug Administration (MDA) campaign goals, (b) the estimated financial savings resulting from integrating LF MDA into Polio immunization campaigns, and (c) the best practices, challenges, and recommendations.
Methods: In 2023, 21,336,057 people in 83 districts were affected by LF and required Preventive Chemotherapy (PC). The National NTD Control Programme (NTDCP) conducted three phases of LF MDA campaigns in those districts.
Ocular loaiasis in France: the first case report from Brittany.
J Ophthalmic Inflamm Infect
November 2024
Univ Brest, CHU Brest, Brest, F-29200, France.
We report the case of a 21-year-old Cameroonian woman residing in France for one year, who presented to our department with left eye discomfort and itching. Examination revealed a mobile translucent cord beneath the nasal-inferior conjunctiva, prompting suspicion of loaiasis. Anesthesia was administered for extraction, revealing a 31 mm male Loa loa.
View Article and Find Full Text PDFAn Overview on Antifilarial Efficacy of Heterocyclic Motifs Encompassing Synthetic Strategies, SAR, and Commercialized Medications.
Curr Top Med Chem
November 2024
ICMR-National Institute of Malaria Research, New Delhi - 110077, India.
Filariasis is one of the oldest, most dangerous, debilitating, disfiguring diseases and often ignores tropical disorders. It presents with a range of clinical symptoms, a low death rate, and a high morbidity rate, which contributes to social discrimination. This condition has major effects on people's socioeconomic circumstances.
View Article and Find Full Text PDFSevere Acute Respiratory Distress in a Child with Hypereosinophilic Syndrome: A Case Report.
JNMA J Nepal Med Assoc
April 2024
Department of Radiodiagnosis, B.P. Koirala Institute of Health Sciences, Dharan, Sunsari, Nepal.
Article Synopsis
- Hypereosinophilic syndrome is a rare condition in children that can cause respiratory distress and affect multiple organs, making accurate diagnosis crucial.
- Immediate treatment with corticosteroids is necessary to stabilize the patient and prevent further organ damage.
- A case study is presented of an adolescent male with severe eosinophilia affecting his lungs, heart, and abdomen, successfully treated with steroids and anthelmintics, emphasizing the need for prompt identification and management of the syndrome.
A Challenging Case of Idiopathic Hypereosinophilic Syndrome: An Itching in the Brain.
Cureus
August 2024
Department of Cardiology, All India Institute of Medical Sciences, Nagpur, Nagpur, IND.
Article Synopsis
- Hypereosinophilia (HE) can be challenging to treat, especially when symptoms persist despite low eosinophil counts, necessitating thorough lab testing to uncover potential causes.
- A case study details a 58-year-old woman with diabetes and hypothyroidism who experienced severe itching and skin lesions, initially linked to pyelonephritis, and presented with elevated eosinophil levels resistant to conventional treatments.
- Following extensive mutation studies and a high bone marrow eosinophil count, the patient was successfully treated with imatinib, leading to normalization of eosinophil levels and symptom resolution over the next 1 to 1.5 years.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!